Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: AJR Am J Roentgenol. 2019 Dec 4;214(3):597–604. doi: 10.2214/AJR.19.21836

TABLE 2:

Radiation Therapy (RT) and MRI Characteristics

First Author [Reference No.] RT
MRI Acquisition
MRI Interpretaron
Type Dose (Gy) ADT, % (No./Total No.) Vendor Model Magnet Strength (T) Endorectal Coil Sequences No. of Readers Consensus Reading Reader Experience (y)
Clarke [24] E and B, B E and B, 45–50.4; B, 90–115 37(144/390) NR NR NR Yes T2-weighted imaging 3 No NR
Fuchsjäger [25] E 81–86.4 54(121/224) GE Signa Horizon 1.5 Yes T2-weighted imaging 2 Yes 5,1.5
Gnep [26] E 74–80 57(42/74) Philips Achieva 3 No T2-weighted imaging, DWI, DCE-MRI 2 Yes 5,30
Gomez-Iturriaga [27] E and B E, 37.5; B, 15 All Philips Achieva 1.5 No T2-weighted imaging, DWI, DCE-MRI 2 Yes Specialist
Goupy [28] E 70–80 All NR NR 1.5 No T2-weighted imaging, DWI, DCE-MRI 2 No Expert
Hegde [29] E and B E, 39.6–50.4; B, 15–24 81(30/37) NR NR 3 Yes for some patients T2-weighted imaging, DWI, DCE-MRI NR NR NR
Jackson [30] E 60–74 All Siemens GBS1, Vision 1.5 No T2-weighted imaging 1 NA Consultant
Joseph [31] E 68–76 58(39/67) Siemens Signa 1.5 Yes T2-weighted imaging, MRS 1 NA >10
Kauffmann [32] E or B or both E and B E, 75.6–79.2; B, 144–145 52(64/123) Philips Achieva 1.5,3 No T2-weighted imaging 2 NR Body imaging
Nguyen [33] E 70–72 None GE NR 1.5 Yes T2-weighted imaging 3 No >4
Riaz [34] E and B E, 50.4; B, LDR of 90–110 or HDRof 16.5–22.5 36(100/279) GE Signa Horizon 1.5,3 Yes T2-weighted imaging 2 Yes GU radiologist
Yamaguchi [35] E 70–78 76(77/101) NR NR 1.5,3 NR T2-weighted imaging, DWI 2 Yes 3,20

Note—ADT = androgen deprivation treatment, E = external beam RT, B = brachytherapy, NR = not reported, DCE-MRI = dynamic contrast-enhanced MRI, NA = not applicale, MRS = MR spectroscopy, LDR = low-dose rate, HDR = high-dose rate, GU = genitourinary.